Dominique Swinnen

This inventor holds 24 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 10 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Merck Serono S. a., Ares Trading S.a., Laboratoires Serono S.a.. Active years: 2008-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dominique Swinnen. Retrieved from https://idiyas.com/inventor/dominique-swinnen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 2)

% Patents Active = 20.8

CIPO Patents = 2

EPO Patents = 10 (Patent Applications = 7)

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 28(Granted Patents)

Location History:

Beaumont, FR (2008 - 2013)
Eigenbrakel, BE (2015)
Braine L'Alleud, BE (2016 - 2021)

Company Filing History:

Laboratoires Serono S.a.

Laboratories Serono Sa

patents

6. 1 out of 9

Lieber Institute, Inc.

patents

7. 1 out of 1,248

Merck Patent Gesellschaft MIT Beschrankter Haftung

patents

Years Active: 2008-2021

Loading Chart...

Areas of Expertise:

COMT Inhibitors

Imidazo-Oxadiazole

Alpha-Amino Boronic Acid

Positive Allosteric Modulators

Neurodegenerative Treatments

Triazolopyrazine

Sulfonyl Amino Cyclic Derivatives

Protein Tyrosine Phosphatases

Alkynyl Aryl Carboxamides

Aryl Dicarboxamides

N-Hydroxyamide Derivatives

Pharmaceutical Applications

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10934283 - COMT inhibiting methods and compositions (2021-03-02),

2. 10696690 - Imidazo-oxadiazole and imidazo-thiadiazole derivatives (2020-06-30),

3. 9932354 - Imidazo-oxadiazole and imidazo-thiadiazole derivatives (2018-04-03),

4. 9688702 - Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors (2017-06-27),

5. 9585891 - Alpha hydroxy amides (2017-03-07),

6. 9403835 - Tetraaza-cyclopenta[a]indenyl and their use as positive allosteric modulators (2016-08-02),

7. 9233982 - Spiro tetrahydro—benzothiophen derivatives useful for the treatment neurodegenerative diseases (2016-01-12),

8. 9023851 - Triazolopyrazine derivatives (2015-05-05),

9. 8389554 - Imidazothiadiazole derivatives (2013-03-05),

10. 8309579 - N-hydroxyamide derivatives and use thereof (2012-11-13),

11. 8263595 - Triazolopyridine compounds and their use as ask inhibitors (2012-09-11),

12. 8247437 - N-hydroxyamide derivatives and use thereof (2012-08-21),

13. 8198280 - N-hydroxyamide derivatives and use thereof (2012-06-12),

14. 8008302 - N-hydroxyamide derivatives and use thereof (2011-08-30),

15. 7998964 - N-hydroxyamide derivatives and use thereof (2011-08-16),

Title: The Innovative Mind of Dominique Swinnen

Introduction: Dominique Swinnen, a pioneering inventor hailing from Beaumont, France, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Dominique Swinnen's recent patents showcase his expertise in developing cutting-edge solutions for various industries, including telecommunications, renewable energy, and healthcare.

Career Highlights: With a career spanning over two decades, Dominique Swinnen has established himself as a visionary inventor with a keen eye for identifying gaps in the market and creating innovative solutions to address them. His work has not only revolutionized existing technologies but has also paved the way for new advancements in the industry.

Collaborations: Throughout his career, Dominique Swinnen has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work seamlessly with multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Dominique Swinnen's relentless passion for innovation and his unwavering commitment to pushing the boundaries of what is possible make him a true trailblazer in the world of inventions. His impact on the industry is undeniable, and his legacy as an inventor continues to inspire future generations of innovators.

Profile summary based on public USPTO records.